Skip to main content
HCPCS Level II/J-Codes/J7674

J7674 HCPCS Level II Code: Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg

Medicare Coverage & Payment

  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: January 1, 2005

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Official Registry Overview & Definition

Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg is a HCPCS Level II code (J7674). CMS assigns coverage code C — Carrier judgment. Short description: Methacholine chloride, neb.

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J7674 in its code family, with their registry titles.

  • J7665 — Mannitol, administered through an inhaler, 5 mg
  • J7667 — Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
  • J7668 — Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
  • J7669 — Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
  • J7670 — Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
  • J7676 — Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
  • J7677 — Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
  • J7680 — Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
  • J7681 — Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
  • J7682 — Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams